IREN Ltd
IREN
TeraWulf
WULF
Bitdeer Technologies
BTDR
Canaan
CAN
Bitfarms
BITF
US Stock MarketDetailed Quotes
CMMB Chemomab Therapeutics
- 1.445
- +0.005+0.35%
Trading Mar 19 09:42 ET
27.25MMarket Cap-1.68P/E (TTM)
1.445High1.410Low15.66KVolume1.410Open1.440Pre Close22.12KTurnover0.13%Turnover RatioLossP/E (Static)18.86MShares2.55052wk High2.01P/B17.08MFloat Cap0.57952wk Low--Dividend TTM11.82MShs Float184.000Historical High--Div YieldTTM2.43%Amplitude0.420Historical Low1.412Avg Price1Lot Size
Chemomab Therapeutics News
Chemomab Therapeutics (CMMB) Gets a Buy From Oppenheimer
Chemomab Therapeutics Sees Cash Runway Through 1Q26
Chemomab Therapeutics 4Q EPS 0.8c >CMMB
Express News | Chemomab Therapeutics Ltd: Q4 Shr Loss Less Than $0.01
Express News | Chemomab Therapeutics Q4 Operating Expenses USD 3.213 Million
Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $7
Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Blueprint Medicines (BPMC)
Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $11
Market-Moving News for February 19th
Express News | Chemomab Therapeutics Shares Are Trading Higher After the Company Announced the Completion of Its End-of-phase 2 FDA Meeting and Alignment on a Single Phase 3 Registration Study for Nebokitug
Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns With FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis
Chemomab Therapeutics Aligns Leadership Incentives With Shareholders
Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $4
Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Cuts Target Price to $11
Chemomab Therapeutics Analyst Ratings
Express News | Chemomab Therapeutics Ltd. : Oppenheimer Cuts Target Price to $11 From $13
Chemomab Therapeutics Sees Cash Runway Through Beginning of 2026
Express News | Chemomab Therapeutics Q3 2024 GAAP EPS $(0.20) Misses $(0.01) Estimate
Chemomab Therapeutics 3Q EPS 1c >CMMB
Earnings Scheduled For November 14, 2024
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.